Table of Contents
What changed
Revenue recovered off a very low base to NZ$6.3m from NZ$1.2m, but the bottom line deteriorated: the net loss attributable to members widened to NZ$1.2b from NZ$1.1b (-12.6%), with the continuing-operations loss moving from NZ$1.1b to NZ$1.1b. The balance sheet contracted sharply — total assets down 20.9% to NZ$12b and total equity down 27.6% to NZ$10.8b — even as cash quadrupled to NZ$2b from NZ$492.5m. Total liabilities climbed to NZ$1.2b from NZ$279.0m. No dividend was declared, consistent with the prior year.
What matters
- Equity fell by NZ$4.1b against a NZ$1.2b reported loss. The NZ$2.9bn gap is not reconcilable from the supplied disclosures and is the single most important read-through: movements through OCI, distributions or capital returns appear to exceed the P&L impact by a wide margin.
- Cash built by NZ$1.5b while non-cash assets shrank by roughly NZ$4.7bn. That points to asset disposals or revaluations rather than operating cash generation (HY23 operating cash flow was already -NZ$498.5m, and a full-year figure is not provided).
- Liabilities more than quadrupled from NZ$279.0m to NZ$1.2b. Without a borrowings breakdown, the driver — draw-down, accruals, or redemption obligations — cannot be identified, but the gearing direction has clearly reversed.
Expectations
No stated targets, forward-work backlog or guidance were provided, so there is no management benchmark to score against. On shape, HY23 represented only 6.2% of FY23 revenue but 55.4% of the FY23 loss, implying a second half that was stronger on revenue recognition but still materially loss-making (implied H2 NPAT of approximately -NZ$535.3m on revenue near NZ$5.9m). The release does not support any inference that the entity is close to operating breakeven.
Quality of result
The result has low observable earnings quality. Revenue at NZ$6.3m is immaterial against a NZ$12.0bn asset base, and the reported loss is dominated by items that are not broken out in the supplied excerpts (no PBT, no tax line, no EBITDA, no operating cash flow, no capex). ROE stepped down to -11.1% from -7.1%. The NZ$1.5bn cash build is the clearest positive data point but, paired with the equity decline, looks consistent with portfolio realisations or redemptions rather than recurring earnings. Cash-conversion cannot be computed from the disclosure, though the HY23 operating cash outflow of NZ$498.5m argues against durable internal funding.
Unresolved
- What reconciles the NZ$2.9bn gap between the equity decline and the reported loss — distributions to members, revaluation losses through OCI, or capital movements?
- What drove the NZ$943.6m increase in total liabilities, and what portion is interest-bearing debt versus member/redemption obligations?
- Full-year operating cash flow, capex and any borrowings schedule are not in the supplied excerpts, so leverage direction and true cash conversion remain unknown.
- Why did revenue step up so sharply in the second half from a near-zero first half, and is that recognition pattern repeatable?
This briefing cannot assess segment economics, asset composition, the nature of the "member" equity structure, or the specific accounting drivers behind the equity contraction because those disclosures are not in the supplied data.
Key metrics
| Metric | FY23 | FY22 | Change |
|---|---|---|---|
| Revenue | $6.3m | $1.2m | +432.3% ↑ |
| Net profit after tax | −$1.2m | −$1.1m | -12.6% ↓ |
| Declared dividend per share | 0.0c | 0.0c | flat |
| Cash and cash equivalents | $2b | $492.5m | +303.6% ↑ |
| Total assets | $12b | $15.2b | -20.9% ↓ |
Analytical metrics
| Metric | FY23 | FY22 | Context |
|---|---|---|---|
| ROE (annualised) | -11.1% | -7.1% | Weakening |
| HY23 share of FY23 revenue | 6.2% | — | Other half was 93.8% |
| HY23 share of FY23 NPAT | 55.4% | — | Other half was 44.6% |
| Profit from continuing operations | −$1.1b | −$1.1b | −$83m |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.
Source-backed analysis from the filing set attached to this briefing.